Table 2 |
||||||
|
Heritability Estimates of factors in African American and European American pedigrees. |
||||||
|
White |
African American |
|||||
|
|
||||||
|
Factor |
Estimate |
S.E. |
Factor |
Estimate |
S.E. |
|
|
|
||||||
|
Post Aspirin Factors |
1W: Collagen/TXM |
0.50 |
0.09 |
1B: Collagen |
0.36 |
0.14 |
|
2W: Epinephrine |
0.61 |
0.09 |
2B: High Dose Collagen |
0.84 |
0.13 |
|
|
3W: High Dose Collagen/TXM |
0.47 |
0.10 |
3B: Epinephrine |
0.46 |
0.15 |
|
|
4W: ADP PRP |
0.34 |
0.09 |
4B: ADP |
0.29 |
0.14 |
|
|
5W: ADP |
0.54 |
0.09 |
5B: ADP PRP |
0 |
||
|
6W: Low Dose Collagen |
0.40 |
0.09 |
6B: Very Low Dose Collagen |
0.32 |
0.15 |
|
|
7W: Very Low Dose Collagen |
0.31 |
0.09 |
7B: ADP/Epinephrine |
0.33 |
0.17 |
|
|
8W: ADP/Epinephrine |
0.05 |
0.09* |
8B: TXM |
0.51 |
0.15 |
|
|
|
||||||
|
Post-adjusted-for-pre Aspirin Factors |
1W: High Dose Collagen |
0.67 |
0.11 |
1B: High Dose Collagen |
0.51 |
0.17 |
|
2W: Epinephrine |
0.41 |
0.10 |
2B: Epinephrine |
0.31 |
0.13 |
|
|
3W: Collagen/TXM |
0.40 |
0.10 |
3B: Collagen |
0.43 |
0.20 |
|
|
4W: Low Dose Collagen |
0.18 |
0.11* |
4B: Low Dose Collagen |
0.08 |
0.12* |
|
|
5W: ADP |
0.27 |
0.10 |
5B: ADP |
0.15 |
0.13* |
|
|
6W: Low Dose Collagen |
0.18 |
0.10* |
6B: Low Dose Collagen |
0.34 |
0.17 |
|
|
7W: High Dose ADP |
0.21 |
0.11* |
7B: Epinephrine/ADP/Collagen |
0.31 |
0.15 |
|
|
8W: Epinephrine/Collagen |
0.26 |
0.10 |
8B: High Dose ADP |
0 |
||
|
|
||||||
|
Pre Aspirin Factors |
1W: Collagen |
0.19 |
0.12* |
1B: Low Dose Collagen |
0.58 |
0.17 |
|
2W: AA/ADP |
0.61 |
0.10 |
2B: Collagen |
0.19 |
0.22* |
|
|
3W: Low Dose Collagen |
0.70 |
0.10 |
3B: Epinephrine |
0.55 |
0.19 |
|
|
4W: Collagen Lag |
0.37 |
0.11 |
4B: Collagen Lag |
0.1 |
0.13* |
|
|
5W: Epinephrine |
0.51 |
0.10 |
5B: ADP |
0.03 |
0.23* |
|
|
6W: ADP/Epinephrine |
0.30 |
0.10 |
6B: Collagen Lag |
0.22 |
0.15* |
|
|
7W: ADP/Epinephrine Lag |
0.07 |
0.10* |
7B: PFA |
0.12 |
0.18* |
|
|
8W: PFA |
0.20 |
0.11* |
8B: AA/ADP/Collagen Lag |
0.58 |
0.17 |
|
|
|
||||||
|
* = not statistically significant at α = 0.05 |
||||||
|
Mathias et al. BMC Medical Genomics 2010 3:22 doi:10.1186/1755-8794-3-22 |
||||||